The largest database of trusted experimental protocols

Stata 14.2 mp

Manufactured by StataCorp
Sourced in United States

STATA 14.2/MP is a statistical software package designed for data analysis, modeling, and visualization. It provides a comprehensive set of tools for managing, analyzing, and presenting data. STATA 14.2/MP offers parallel processing capabilities to speed up computations and handle large datasets efficiently.

Automatically generated - may contain errors

Lab products found in correlation

9 protocols using stata 14.2 mp

1

Chlamydia Screening and Intention

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data collected online through the Qualtrics platform was downloaded and processed in SPSS. STATA14.2/MP was used for further data analysis, including sample description and exploratory factor analysis (i.e. Principal Component Analysis (PCA) with varimax rotation and Kaiser normalisation) as informed by the initial pilot testing phase. Factors, assigned with the PCA generated item scores, along with other key sociodemographic variables were then forceentered into the initial multivariable logistic regression model as blocks. Following a hierarchical model reduction procedure, the final parsimonious model was produced. Statistical significance testing was set at P < 0.05.
We report here the following key outcomes: (1) the positive screening rate of chlamydia through self-collected urine samples (a proxy of active campaign engagement); ( 2) key factors informing client segmentation of the survey samples (a proxy of whether tailored messages reached diverse sexually active young people); and (3) key factors associated with their intention (= 'definitely yes') to have an STI test within the next 12 months (a proxy of future behavioural change intention).
+ Open protocol
+ Expand
2

Statistical Analysis of Two-Tailed Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
All analyses were two-tailed and α was set at 0.05. Analyses were performed using STATA 14.2/MP (College Station, Texas).
+ Open protocol
+ Expand
3

Aldosterone Secretion and KCNJ5 Mutation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients were categorized by the presence or absence of 1 mg DST>1.5 (Table 1) and by the presence of mutated or wild-type (WT) KCNJ5 (Table 2). The Fisher exact test was used for categorical variables and the Mann-Whitney U test for continuous variables. An interaction term, KCNJ5 mutation × 1 mg DST<1.5 was generated to test whether the clinical outcome of 1 mg DST<1.5 was modified by the presence of a KCNJ5 mutation.
Multivariable regression analysis was performed to investigate the relationship between KCNJ5 mutation and 1 mg DST>1.5 (Table 3, Methods in the Data Supplement).
A conditional effect plot was drawn based on the fitted results of the regression model to predict 1 mg DST>1.5. We chose the turning point with maximal the slope change of the tangent line.
A 2-sided P<0.05 was considered significant. Statistical analyses were performed using Stata 14.2 MP (Stata Corporation, College Station, TX) and R software, version 3.4.4 (Free Software Foundation, Inc, Boston, MA).
Additional detailed descriptions of materials and methods are available in the Data Supplement.
+ Open protocol
+ Expand
4

Factors Predicting Ischemic and Hemorrhagic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols
Demographic and clinical variables in subjects with and without each type of neurologic injury (ischemic stroke, hemorrhagic stroke, and brain death) were compared by unpaired t-test, chi-square test, or Mann-Whitney U test as appropriate. Results are expressed as the mean with standard deviation for quantitative variables and as proportions for categorical findings. Ordinal or categorical data are reported as numbers and percentages. A p value <0.05 was considered statistically significant. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using logistic regression. We carefully selected clinically relevant variables that have biologically plausible associations or causality for inclusion in multivariable logistic regression analysis to identify factors that predicted each ischemic and hemorrhagic stroke. All analyses were carried out in STATA 14.2/MP (StataCorp, LLP, College Station, TX, USA).
+ Open protocol
+ Expand
5

Evaluating Student Clinical Experiences

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inclusion criteria for this analysis consisted of the following: (1) student provided informed consent for research, (2) successful program graduation, and (3) data audit by the instructor was performed and deemed acceptable.
Students with < 10 patient encounters were presumed to have been erroneously marked as audited with good data and excluded from the analysis. Records with missing or invalid age were removed from the age‐specific analysis.
Descriptive statistics were calculated. The distribution of all continuous variables was assessed using visual inspection of histograms and measurement of skewness. Skewness of 0.5 or higher was observed and non‐parametric statistics are reported. Categorical variables are summarized using frequencies and percentages for categorical variables and medians with interquartile ranges (IQR) are presented for non‐normally distributed continuous variables. Analyses were stratified by encounter setting (hospital or field). To account for the potential variability over time, a non‐parametric test of trend was used to evaluate for monotonic increase or decrease in the number of patient encounters and hours per student annually throughout the study period. All analyses were performed using STATA 14.2MP (STATA corporation, College Station, Texas, USA).
+ Open protocol
+ Expand
6

RNA-Seq analysis of cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from cell lines and prepared by TruSeq. We performed RNA sequencing (RNA-seq) with an Illumina HiSeq 2500 (Illumina, San Diego, CA). Resultant stranded paired-end 100-bp sequences were mapped to the hg19 human genome with the STRONGARM pipeline developed for the Pediatric Cancer Genome Project34 (link) and counted with HTSEQ35 (link). Statistical testing to determine differential expression was performed in R by using the voom and limma packages. By using our rnapeg in-house tool, exon junction reads were extracted to visualize alternative splicing and select differential junctions and to supplement multivariate analysis of transcript splicing (MATS) 3.0.8 (python 2.7.2)36 . Results with a false discovery rate less than 5% in MATS analyses were tested for category enrichment with Enrichr37 (link),38 (link). Scatterplots, pie charts, and bar charts were produced in STATA 14.2/MP (College Station, TX). Principle component analyses and heat maps were produced with Partek Genomics Suite 6.6 (St Louis, MO). GO analysis was done with Gene Ontology enRIchment anaLysis and vizuaLizAtion tool (Gorilla)39 (link).
+ Open protocol
+ Expand
7

Mortality Analysis of Asbestos Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standardized mortality ratio (SMR) was calculated with its 95% confidence interval (CI) for the whole city, and the long‐term residents’ cohort compared to the short‐term residents according to all‐cause deaths, lung cancer, and mesothelioma, by dividing the number of observed deaths by the number of expected deaths that would have occurred. The expected number of deaths was calculated using the Japanese annual sex‐ and age‐specific death rates. These death rates were calculated by dividing the number of deaths by the national population within each 5‐year age group and sex category for a calendar year. Both national population and number of deaths were available from the Portal Site of Official Statistics of Japan (e‐Stat), also known as a portal site of Japanese Government Statistics. The 95% CIs for SMRs were calculated using the Poisson distribution to determine upper and lower band multipliers applied to the SMR.
In addition, the follow‐up was divided into 3 analysis periods: 2002‐2006 (5 years), 2007‐2011 (5 years), and 2012‐2015 (4 years).
Stata 14.2/MP (StataCorp, College Station, TX, USA) was used for all statistical analyses, and the level of significance was set at P‐value of <.05. Informed consent was waived because official data were used. The study protocol was approved by the Institutional Review Board of Osaka University (Suita, Japan).
+ Open protocol
+ Expand
8

Trends in Older Adults Kidney Transplant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cuzick test of trend was used to compare changes in number of older adults with prior nkSOT who underwent subsequent KT over the study period. Comparison of donor and recipient characteristics were performed using chi-squared test for categorical variables and t-tests for continuous variables. All analyses were two-tailed and α was set at 0.05. All analyses were performed using Stata 14.2/MP (College Station, Texas).
+ Open protocol
+ Expand
9

Comparative Analysis of Study Cohorts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Comparison of candidate characteristics was performed using chi-squared test for categorical variables and t tests or Wilcoxon rank sum for continuous variables. All analyses were 2-tailed and a was set at 0.05. All analyses were performed using Stata 14.2/MP (College Station, TX).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!